About Barrx Medical
Barrx Medical is a Healthcare company based in Sunnyvale (United States) founded in 2003, and was acquired by Covidien in November 2011. Ablation technologies for Barretts Esophagus treatment are developed. Barrx Medical has raised $15 million across 1 funding round from investors including Frazier Healthcare Partners, Covidien and Greenspring Associates. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Therapeutic Devices. Its legal entity is BARRX Medical, Inc. Its competitors include EndoGastric Solutions, EndoChoice and CoapTech; 3 of its 3 listed competitors have raised funding.
Company details
Barrx Medical was founded in 2003 and is based in Sunnyvale, United States. Operations are conducted in the medical device sector, with a focus on research into Barretts esophagus and related treatments. Endoscopic ablation systems, including the Flex System, 360 RFA Balloon Catheter, 90 RFA Focal Catheter, 60 RFA Focal Catheter, Ultra Long RFA Focal Catheter, and Channel RFA Endoscopic Catheter, are provided for clinical use in gastroenterology procedures.
- Total Equity Funding$15M (USD)
in 1 rounds
- Latest Funding Round$15M (USD), Series D
Jul 2010
- InvestorsFrazier Healthcare Partners
& 6 more
- Acquired byCovidien
(Nov 2011)
Funding Insights of Barrx Medical
Barrx Medical has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series D round of $15 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15M
- Total Rounds 1
- Last Round Series D — $15M
- First Round $15M
(Jul 2010)
- Investors Count 6
All 1 funding rounds of Barrx Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2010 | $15M | Series D | – | – |
7 investors in total: 7 institutional.
Investors in Barrx Medical
Barrx Medical has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Frazier Healthcare Partners, Covidien and Greenspring Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investment and entrepreneur support services. | hcp.com | |||
Investments are made in life sciences firms across all stages. | delphiventures.com | Menlo Park, United States | ||
Early stage venture capital firm investing in the US | alloyventures.com | Palo Alto, United States | ||
Healthcare sector private equity investments are managed by the firm. | 1991 | frazierhealthcare.com | Seattle, United States | |
VC firm investing in the US | shv.com | Palo Alto, United States | ||
Diversified investment management firm | 2000 | greenspringassociates.com | Owings Mills, United States | |
Medical devices for minimally invasive therapies are provided globally. | 2007 | covidien.com | Dublin, Ireland |
Investor details for Barrx Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Barrx Medical
3 dated milestones of Barrx Medical across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Barrx Medical is founded.
- Funding First funding round of $15.0M.
- Exit Acquired by Covidien.
Competitors of Barrx Medical
Barrx Medical has 3 listed competitors in our database, 3 of them funded. They include EndoGastric Solutions, EndoChoice and CoapTech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endogastricsolutions.com | 2002 | San Mateo, United States | $355.2M | 80 | Incisionless transoral procedures for upper GI diseases are developed. | |
| endochoice.com | 2008 | Alpharetta, United States | $115.96M | 414 | Devices, systems, and services are provided for GI specialists. | |
| coaptech.com | 2016 | Baltimore, United States | $16.52M | Minimally invasive gastrostomy feeding tube placement method is developed. |
Detailed competitors of Barrx Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Barrx Medical
Websites that share an audience with Barrx Medical (barrx.com).
Websites whose visitors overlap most with Barrx Medical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| linkedin.com | 100% | 1.9B | #18 | View details | |
| givenimaging.com | 69% | View details |
Top companies in Gastroenterology
3 companies that operate in the same segment as Barrx Medical (Gastroenterology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | 411 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Barrx Medical
Barrx Medical was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Barrx Medical is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Barrx Medical is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series D of $15M, raised on Jul 2010.
Barrx Medical was founded in 2003 and is based in Sunnyvale, United States. Operations are conducted in the medical device sector, with a focus on research into Barretts esophagus and related treatments. Endoscopic ablation systems, including the Flex System, 360 RFA Balloon Catheter, 90 RFA Focal Catheter, 60 RFA Focal Catheter, Ultra Long RFA Focal Catheter, and Channel RFA Endoscopic Catheter, are provided for clinical use in gastroenterology procedures.
Barrx Medical's top competitors include CoapTech, EndoChoice and EndoGastric Solutions.
Barrx Medical has 7 investors. Key investors include Frazier Healthcare Partners, Covidien, Greenspring Associates, Highland Capital Partners, and Delphi Ventures.
Barrx Medical operates through Barrx Medical, Inc..
Yes. Barrx Medical was acquired by Covidien in November 2011.